Are you Dr. Johnston?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 36 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
938 Bannock St
Ste 300
Denver, CO 80204Phone+1 303-914-8800Fax+1 303-716-3777
Summary
- Dr. Robert Johnston, MD is a board certified radiologist in Denver, Colorado. He is currently licensed to practice medicine in Colorado, New Jersey, and California. He is affiliated with Intermountain Health Saint Joseph Hospital, Presbyterian/St. Luke's Medical Center, and Rose Medical Center.
Education & Training
- University of ColoradoResidency, Radiology-Diagnostic, 1989 - 1990
- University of California Davis HealthResidency, Radiology-Diagnostic, 1985 - 1989
- HCA HealthONE /Presbyterian-St Luke’s Medical CenterInternship, Transitional Year, 1984 - 1985
- University of Colorado School of Medicine Anschutz Medical CampusClass of 1984
Certifications & Licensure
- AZ State Medical License 1959 - 2026
- TX State Medical License 2020 - 2026
- FL State Medical License 2020 - 2026
- NY State Medical License 2021 - 2026
- MT State Medical License 2015 - 2026
- CA State Medical License 2021 - 2025
- SC State Medical License 2021 - 2025
- American Board of Radiology Diagnostic Radiology
- Join now to see all
Publications & Presentations
PubMed
- 88 citationsIL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in MelanomaJoe-Marc Chauvin, Mignane B. Ka, Ornella Pagliano, Carmine Menna, Quanquan Ding
Clinical Cancer Research. 2020-10-15 - 85 citationsCD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells.Matthias Braun, Amelia Roman Aguilera, Ashmitha Sundarrajan, Dillon Corvino, Kimberley Stannard
Immunity. 2020-10-13 - 59 citationsA conserved intratumoral regulatory T cell signature identifies 4-1BB as a pan-cancer targetZachary T. Freeman, Thomas R. Nirschl, Daniel H. Hovelson, Robert J. Johnston, John J. Engelhardt
The Journal of Clinical Investigation. 2020-06-24